No headlines found.
No press releases found.
No news found.
The Fund is an actively managed ETF that seeks to achieve its investment objective by investing in equities of companies tied economically to markets (excluding China) that are not treated as developed markets in the MSCI World Index. The Fund invests in companies that GMO believes are likely to benefit from growth in emerging markets and from the widespread trend of transitioning supply chains out of China to other emerging markets. In selecting securities for the Fund, GMO uses a combination of proprietary quantitative and fundamental investment methods to identify emerging market equities. GMO determines the Fund's investment universe through a top-down analysis of those countries, regions and sectors that GMO believes are positioned to benefit from the secular trend. GMO uses a combination of proprietary quantitative and fundamental investment methods that focus on growth, quality, valuation and other patterns of information, such as price movement or volatility of an asset class, security, or market. GMO also may consider ESG (environmental, social and governance) criteria.
Gmo Beyond China ETF trades on the ARCA stock market under the symbol BCHI.
As of April 10, 2026, BCHI stock price climbed to $34.60 with 3,204 million shares trading.
BCHI has a market cap of $16.61 million. This is considered a Sub-Micro Cap stock.
BCHI has outperformed the market in the last year with a price return of +56.1% while the SPY ETF gained +30.9%. BCHI has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +10.5% and +11.1%, respectively, while the SPY returned -1.8% and +7.2%, respectively.
BCHI support price is $33.62 and resistance is $35.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCHI shares will trade within this expected range on the day.
